<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-150598" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Postbariatric Surgery Hypoglycemia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Athavale</surname>
            <given-names>Anand</given-names>
          </name>
          <aff>Presbyterian Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ganipisetti</surname>
            <given-names>Venu Madhav</given-names>
          </name>
          <aff>Presbyterian Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Anand Athavale declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Venu Madhav Ganipisetti declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>15</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-150598.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Bariatric surgery has been reported to help achieve more significant and sustained weight loss than non-surgical management in patients with severe obesity. The number of bariatric surgeries performed has increased yearly from 2011 through 2019. Post-bariatric surgery hypoglycemia is an increasingly recognized complication. It can have significant effects on the quality of life of an individual. This activity reviews the various patterns of post-bariatric surgery hypoglycemia, pathophysiology, evaluation, differential diagnosis, and treatment and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of post-bariatric surgery hypoglycemia.</p></list-item><list-item><p>Identify the typical presentation of a patient with post-bariatric surgery hypoglycemia.</p></list-item><list-item><p>Implement recommended diagnostic evaluation criteria for differentiating etiologies of hypoglycemia</p></list-item><list-item><p>Apply best practices in the treatment of post-bariatric surgery hypoglycemia including medical nutrition therapy, pharmacotherapy, and surgical management.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=150598&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=150598">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-150598.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Obesity is a common, chronic, and often relapsing disease characterized by excess adipose tissue accumulation. The World Health Organization (WHO) considers a body mass index (BMI) &#x02265;30 kg/m as obese and defines severe obesity as a BMI of 40 or higher (also classified as Class 3 obesity).&#x000a0;</p>
        <p>According to the National Nutritional Health and Examination Survey (NHANES) data (2017&#x000a0;to 2020), the prevalence of obesity among children and adolescents aged 2&#x000a0;to 19 years is 19.7%; among adults aged 20 and over, the age-adjusted prevalence of obesity is 41.9%, and the prevalence of severe obesity is 9.2%. Obesity increases the risk of other medical conditions such as diabetes mellitus type 2, fatty liver disease, hypertension, coronary artery disease, stroke, dementia, obstructive sleep apnea, osteoarthritis, dysthymia, etc.<xref ref-type="bibr" rid="article-150598.r1">[1]</xref>&#x000a0;According to the Centers for Disease Control and Prevention (CDC), the estimated annual obesity-related medical care cost was approximately $173 billion in 2019.&#x000a0;</p>
        <p>Bariatric surgery has been reported to help achieve more significant and sustained weight loss than non-surgical management in patients with severe obesity.<xref ref-type="bibr" rid="article-150598.r2">[2]</xref>&#x000a0;According to data from the American Society for Metabolic and Bariatric Surgery (ASMBS), the number of bariatric surgeries performed has increased yearly from 2011 through 2019.<xref ref-type="bibr" rid="article-150598.r3">[3]</xref>&#x000a0;Hence, it is essential to be aware of post-surgery adverse events.</p>
        <p>Post-bariatric surgery hypoglycemia is an increasingly recognized complication. It has been referred to as late dumping syndrome, reactive hypoglycemia, or postprandial hyper-insulinemic hypoglycemia. However, there is no specific definition of post-bariatric surgery hypoglycemia. It has been thought of as a condition characterized by symptoms of hypoglycemia occurring after a meal in individuals who have undergone weight loss surgery. However, with more sensitive methods, such as continuous glucose monitoring (CGM), other patterns of hypoglycemia are being identified. Post-bariatric surgery hypoglycemia is commonly associated with Roux-en-Y gastric bypass (RYGB) surgery. However, it can also occur with different types of bariatric surgeries, such as sleeve gastrectomy (SG) and laparoscopically adjustable gastric band (LAGB).<xref ref-type="bibr" rid="article-150598.r3">[3]</xref></p>
      </sec>
      <sec id="article-150598.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology is suspected to be related to altered anatomy post-surgery, its effects on the transition time of ingested food, and hormonal and glycemic patterns. The effects are usually compounded by consuming large meals of simple sugars and refined fats.<xref ref-type="bibr" rid="article-150598.r3">[3]</xref></p>
        <p>Impairment of fasting glucose regulation has also been recently recognized, although the underlying mechanisms are yet to be understood.<xref ref-type="bibr" rid="article-150598.r4">[4]</xref></p>
      </sec>
      <sec id="article-150598.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Reported risk factors for hypoglycemic complications following bariatric surgery include female sex, Roux-en-Y gastric bypass (RYGB) surgery history, longer time since surgery, and absence of preexisting diabetes.<xref ref-type="bibr" rid="article-150598.r5">[5]</xref><xref ref-type="bibr" rid="article-150598.r6">[6]</xref>&#x000a0;However, it's worth noting that approximately 70% to 80% of individuals undergoing bariatric surgery are female.<xref ref-type="bibr" rid="article-150598.r7">[7]</xref></p>
        <p>A randomized controlled trial found no significant difference in the occurrence of hypoglycemia after SG compared with RYGB,&#x000a0;but RYGB may be associated with more severe episodes.<xref ref-type="bibr" rid="article-150598.r8">[8]</xref> In a study using continuous glucose monitoring, Nocturnal and asymptomatic hypoglycemia has been reported to occur more frequently after Sleeve Gastrectomy (SG) than RYGB, whereas RYGB is associated more often with post-prandial and symptomatic hypoglycemic events.<xref ref-type="bibr" rid="article-150598.r4">[4]</xref></p>
        <p>There is wide variation in the reported prevalence of hypoglycemia post-bariatric surgery. This variation is likely due to different study methodologies, variability in testing, and definitions of hypoglycemia used. However, with increasing recognition of conditions such as asymptomatic hypoglycemia, meal-independent hypoglycemia, and the use of more sensitive methods such as CGM, it has become apparent that the condition is underreported.&#x000a0;</p>
        <p>Studies that have relied on patient recall of symptoms have noted a prevalence of post-prandial symptomatic hypoglycemia ranging from 0.1 to 34%.<xref ref-type="bibr" rid="article-150598.r3">[3]</xref>&#x000a0;A prospective study that used Oral Glucose Tolerance Test (OGTT) reported a prevalence of 25.6%.<xref ref-type="bibr" rid="article-150598.r9">[9]</xref>&#x000a0; Smaller studies using more sensitive methods, such as CGM, reported hypoglycemic episodes in as many as 55 to 75% of the patients studied.<xref ref-type="bibr" rid="article-150598.r4">[4]</xref><xref ref-type="bibr" rid="article-150598.r10">[10]</xref>&#x000a0;</p>
        <p>The actual burden of this condition and risk factors are yet to be determined&#x000a0;and would require extensive studies.</p>
      </sec>
      <sec id="article-150598.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology still needs to be fully elucidated. There are likely different mechanisms underlying different patterns of hypoglycemia.&#x000a0;</p>
        <p>Postprandial hypoglycemia is thought to occur in two phases:</p>
        <list list-type="order">
          <list-item>
            <p>Induction of post-meal hyper-insulinemia</p>
          </list-item>
          <list-item>
            <p>Maintenance of inappropriately high levels of insulin</p>
          </list-item>
        </list>
        <p>
<bold>Post-Meal Hyperinsulinemia</bold>
</p>
        <p>In individuals with post-RYGB hypoglycemia, ingested food induces faster, higher glycemic peaks and lower nadirs.<xref ref-type="bibr" rid="article-150598.r11">[11]</xref>&#x000a0;</p>
        <p>Glucagon-like peptide -1 (GLP -1) is secreted by the intestinal L cells in response to ingested food, and it contributes to insulin secretion in a dose-dependent (glucose-dependent) manner. In individuals with post-bariatric surgery hypoglycemia, it was noted that meal-induced GLP-1 levels are elevated and likely result in an exaggerated insulin response compared to those without symptoms of hypoglycemia.<xref ref-type="bibr" rid="article-150598.r3">[3]</xref></p>
        <p>Ghrelin suppresses insulin secretion and opposes its action. Its secretion is decreased after gastric bypass surgery, which can contribute to hypoglycemia.<xref ref-type="bibr" rid="article-150598.r12">[12]</xref><xref ref-type="bibr" rid="article-150598.r13">[13]</xref>&#x000a0;Non-hormonal gut factors may also contribute to meal-induced hyper-insulinemia.<xref ref-type="bibr" rid="article-150598.r14">[14]</xref></p>
        <p><bold>Maintenance of Inappropriately High Levels of Insulin</bold>&#x000a0;</p>
        <p>Specific mechanisms perpetuate high insulin levels in individuals with post-RYGB hypoglycemia, even after developing hypoglycemia. They have lower beta cell suppression in response to low blood sugar levels. They also may have diminished insulin clearance. Increased insulin sensitivity after weight loss and disturbed counter-regulatory hormonal responses to hypoglycemia also have a role.<xref ref-type="bibr" rid="article-150598.r3">[3]</xref></p>
        <p>The effects of other insulinotropic factors and changes in insulin sensitivity may be contributory, although they still need to be fully understood. Increased beta cell mass was previously implicated; however, it is currently not considered a significant cause of hypoglycemia.<xref ref-type="bibr" rid="article-150598.r3">[3]</xref>&#x000a0;The mechanisms for meal-independent hypoglycemia are even less known.<xref ref-type="bibr" rid="article-150598.r4">[4]</xref></p>
      </sec>
      <sec id="article-150598.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>No consistent histopathologic pattern has been found.&#x000a0;Initial reports of &#x003b2;-cell hypertrophy and islet cell hyperplasia were seen in the pancreas tissue samples from patients who underwent partial pancreatectomy to manage postprandial hypoglycemia&#x000a0;after bariatric surgery.<xref ref-type="bibr" rid="article-150598.r15">[15]</xref>&#x000a0;However, these findings have been disputed. Other studies have reported the presence of increased beta cell nuclear diameter in patients who experience post-bariatric surgery hypoglycemia.<xref ref-type="bibr" rid="article-150598.r16">[16]</xref></p>
      </sec>
      <sec id="article-150598.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with late dumping syndrome can present autonomic or neuroglycopenic hypoglycemia symptoms months to years after the surgery, usually 1&#x000a0;to 3 hours after a meal. The consumption of large meals rich in simple carbohydrates exacerbates symptoms.<xref ref-type="bibr" rid="article-150598.r3">[3]</xref></p>
        <p>The autonomic symptoms can be anxiety, sweating, tremors, and palpitations. Neuroglycopenic symptoms include confusion, fatigue, light-headedness, slurred speech, blurred vision, and disorientation. Seizures&#x000a0;or a coma may occur in severe cases.<xref ref-type="bibr" rid="article-150598.r17">[17]</xref></p>
        <p>Postprandial hypoglycemia is seen more commonly after RYGB, whereas meal-independent hypoglycemia occurs more commonly after Sleeve Gastrectomy.<xref ref-type="bibr" rid="article-150598.r4">[4]</xref>&#x000a0;However, postprandial hypoglycemia can also be seen after SG and LAGB, and some patients can have a mixed pattern.&#x000a0;</p>
        <p>Some individuals with repeated episodes of hypoglycemia may develop hypoglycemia unawareness defined as the development of symptoms of neuroglycopenia before the onset of autonomic warning symptoms.<xref ref-type="bibr" rid="article-150598.r18">[18]</xref></p>
        <p>There are no physical exam findings specific to this condition.</p>
      </sec>
      <sec id="article-150598.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A consensus on the criteria for diagnosing postprandial hyperinsulinemic hypoglycemia after bariatric surgery is yet to be developed. Making a diagnosis can be challenging due to the variation in symptoms and the definitions of hypoglycemia.</p>
        <p>The International Hypoglycemia Study Group considers a glucose level of &#x0003c;3.0 mmol/L (&#x0003c;54 mg/dL) to indicate clinically significant hypoglycemia.<xref ref-type="bibr" rid="article-150598.r19">[19]</xref></p>
        <p>The ASMBS recommends the following criteria for diagnosis of postprandial hyperinsulinemic hypoglycemia or late dumping syndrome:<xref ref-type="bibr" rid="article-150598.r3">[3]</xref></p>
        <list list-type="order">
          <list-item>
            <p>Symptoms occurring more than one year after surgery</p>
          </list-item>
          <list-item>
            <p>Normal fasting glucose and insulin levels</p>
          </list-item>
          <list-item>
            <p>Correlation of symptoms with hypoglycemia, followed by spontaneous resolution of hypoglycemia</p>
          </list-item>
          <list-item>
            <p>Positive provocative test.</p>
          </list-item>
        </list>
        <p>Others have recommended additional criteria and specific cut-off values - the presence of hyperinsulinemia (serum insulin &#x0003e;50 &#x000b5;U/L or 300 pmol/L) concurrently with hypoglycemia (plasma glucose &#x0003c;50 mg/dL or 2.8 mmol/L) after a mixed meal.<xref ref-type="bibr" rid="article-150598.r20">[20]</xref></p>
        <p>Provocative tests such as the oral glucose tolerance test (OGTT) and mixed meal tolerance test (MMTT) aid in the diagnosis. OGTT involves the administration of 75 to 100 grams of glucose followed by serial serum glucose measurements at intervals up to 120 to 240 minutes after administration. In MMTT, a standardized meal of carbohydrates, protein, and fat is administered. Glucose and insulin levels are determined during fasting and 30-minute intervals after the mixed meal.<xref ref-type="bibr" rid="article-150598.r3">[3]</xref>&#x000a0;</p>
        <p>In patients with bariatric surgery, an oral glucose tolerance test (OGTT) for evaluation of meal-induced hypoglycemia may not be well tolerated since hyperosmolar glucose liquid loads may provoke severe hypoglycemia and should be avoided. A mixed meal test with carbohydrates, protein, and fat may be better, but this approach remains controversial. Any provoked tests should be&#x000a0;performed in a supervised setting with trained medical personnel equipped to deal with the situation due to the risk of a severe hypoglycemic event.<xref ref-type="bibr" rid="article-150598.r11">[11]</xref></p>
        <p>Continuous glucose monitoring (CGM) is more sensitive and specific than provocative tests.<xref ref-type="bibr" rid="article-150598.r21">[21]</xref>&#x000a0;CGM provides more details regarding glucose excursions while allowing subjects to follow their usual feeding patterns.&#x000a0;CGM has the added benefit of capturing asymptomatic hypoglycemia and fasting hypoglycemia episodes.</p>
        <p>In individuals with fasting hypoglycemia, the possibility of insulinoma should be considered. Workup for insulinoma entails a 72-hour fasting test and computerized tomography (CT)/magnetic resonance imaging (MRI). Invasive studies such as endoscopic ultrasound or selective arterial calcium stimulation testing may be considered if the imaging is unrevealing.<xref ref-type="bibr" rid="article-150598.r3">[3]</xref></p>
        <p>As the name implies, a 72-hour fasting test entails fasting for 72 hours (calorie-free beverages are allowed). Capillary blood samples for glucose are collected every 2 hours, and venous blood sugar samples are collected every 6 hours. Once blood sugar levels are less than 60 mg/dL, insulin, C-peptide, pro-insulin, and beta-hydroxybutyrate should also be collected.<xref ref-type="bibr" rid="article-150598.r22">[22]</xref>&#x000a0;Concurrently with hypoglycemia, a high insulin level, high&#x000a0;C-peptide levels, and absence of sulfonylurea suggest insulinoma.<xref ref-type="bibr" rid="article-150598.r23">[23]</xref></p>
        <p>Some clinicians consider the presence of Whipple&#x02019;s triad (Measured low blood glucose with corresponding symptoms of hypoglycemia and low blood glucose and the relief of symptoms when low blood glucose is corrected) essential for diagnosis. However, since some people can have atypical symptoms of hypoglycemia or asymptomatic hypoglycemia, reliance on Whipple&#x02019;s triad may miss the diagnosis in these individuals. Hence, a clinician needs to be aware of the various patterns of hypoglycemia, as this may inform the choice of diagnostic tests ordered.&#x000a0;</p>
        <p>It is also crucial to consider other conditions, such as insulinoma, adrenal insufficiency, liver dysfunction, and medication-induced hypoglycemia, and rule them out when indicated based on history and physical examination.</p>
        <p>Diagnostic evaluation for differentiating etiologies of hypoglycemia is summarized in Table 1.&#x000a0;</p>
        <table-wrap id="article-150598.table0" position="float" orientation="portrait">
          <caption>
            <title>Table 1.</title>
          </caption>
          <table style="height: 247px;" border="1" cellspacing="1" cellpadding="20">
            <tbody>
              <tr style="height: 13px;">
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Lab</td>
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Late dumping Syndrome</td>
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Insulinoma</td>
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Insulin secretagogue use</td>
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Exogenous Insulin use</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Post meal insulin</td>
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Increased</td>
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Increased</td>
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Increased (after use)</td>
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Increased (after use)</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Fasting insulin</td>
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Normal</td>
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Increased</td>
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Increased (after use)</td>
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Increased (after use)</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">C-peptide (collected during the hypoglycemic event)</td>
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Increased</td>
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Increased</td>
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Normal/Increased</td>
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Decreased</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Sulfonyl/meglitinide screen (collected during hypoglycemia)</td>
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Negative</td>
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Negative</td>
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">Positive</td>
                <td style="width: 120px; height: 13px;" rowspan="1" colspan="1">&#x000a0;Negative</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="article-150598.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Medical Nutrition Therapy</bold>
</p>
        <p>Medical nutritional therapy is the first line of treatment. A strategy of consuming small portions of low glycemic index carbohydrates (30 grams of carbohydrates&#x000a0;per meal, 15 grams per snack), adequate protein consumption (30 grams per meal and total of 60&#x000a0;to 80 grams/day), adequate fat consumption (15 grams/meal, 5 grams/snack), spacing meals 3&#x000a0;to 4 hours apart, avoidance of alcohol, caffeine, and fluids with meals is recommended.&#x000a0;</p>
        <p>Avoiding high glycemic index foods is essential because a sudden rise in glucose can trigger more insulin release after meals and contribute to significant post-prandial hypoglycemia. High glycemic foods are digested quickly, whereas low glycemic foods are digested relatively slowly and cause a relatively slow rise in glucose levels.<xref ref-type="bibr" rid="article-150598.r24">[24]</xref></p>
        <p>
<bold>Pharmacotherapy</bold>
</p>
        <p>Pharmacotherapy may be considered for individuals with moderate-severe symptoms refractory to nutritional therapy; however, large-scale studies comparing the efficacy of medications are yet to be performed. The choice in the use of medications depends on the clinician's preference/experience and patient choice. The use of nifedipine, acarbose, GLP-1 analogs, diazoxide, and somatostatin analogs for treatment has been reported in case reports and small case series.&#x000a0;&#x000a0;</p>
        <p>Acarbose, an alpha-glucosidase inhibitor, delays the digestion of carbohydrates and may help decrease post-prandial glucose level spikes. Diazoxide acts via ATP-sensitive Potassium channels to inhibit the secretion of insulin. Somatostatin analogs slow gastric and small bowel transit of ingested material, affecting the release of hormones, insulin, and vasculature tone. Calcium channel blockers work via calcium channels on Beta cells to affect insulin secretion.<xref ref-type="bibr" rid="article-150598.r25">[25]</xref><xref ref-type="bibr" rid="article-150598.r26">[26]</xref></p>
        <p>The International consensus on diagnosing and managing dumping syndrome endorses using acarbose as the first-line pharmacotherapeutic agent and using somatostatin analogs in patients not responding to acarbose. Usually, acarbose at a dose of 50&#x02013;100 mg three times daily, with meals recommended. The adverse effects associated with acarbose are bloating and flatulence. Somatostatin analogs require frequent injections.<xref ref-type="bibr" rid="article-150598.r25">[25]</xref> Some clinicians have used combination therapy.</p>
        <p>A recent randomized, placebo-controlled crossover study (PREVENT) reported promising results with Avexitide, a GLP -1 antagonist, in treating post-bariatric surgery hypoglycemia.<xref ref-type="bibr" rid="article-150598.r27">[27]</xref>&#x000a0;The "DEEP-EMPA" trial investigates the effects of Empagliflozin, a sodium-glucose cotransporter 2-inhibitor, on hypoglycemia post-bariatric surgery.<xref ref-type="bibr" rid="article-150598.r28">[28]</xref></p>
        <p>
<bold>Surgical Management</bold>
</p>
        <p>Surgical management may be considered for patients with moderate-to-severe symptoms refractory to nutritional therapy and pharmacotherapy. As with pharmacotherapy, large-scale trials comparing efficacy and safety are yet to be performed; surgical modality depends on the clinician's preference/expertise, comorbidities, anatomy, and patient choice. Gastrostomy tube placement in the remnant stomach, gastric outlet restriction surgery, RYGB reversal, and conversion of RYGB to SG have been reported in small case series. A partial pancreatectomy has been performed for this indication. However, it has not been found effective, and the ASMBS does not recommend it.<xref ref-type="bibr" rid="article-150598.r3">[3]</xref></p>
      </sec>
      <sec id="article-150598.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>An insulinoma should be considered in the differential diagnosis and ruled out. Postprandial hypoglycemia has been seen in individuals with nonalcoholic fatty liver disease (NAFLD); obesity is a risk factor for developing NAFLD.<xref ref-type="bibr" rid="article-150598.r29">[29]</xref></p>
        <p>Exogenous insulin or secretagogue use may also induce hypoglycemia; C peptide levels (low in case of exogenous insulin, normal or elevated with secretagogues) and medication screening may help investigate these causes.</p>
        <p>In the appropriate context, the differential diagnosis may also consider hormone deficiencies, autoimmune conditions, or non-islet cell tumors.<xref ref-type="bibr" rid="article-150598.r11">[11]</xref></p>
      </sec>
      <sec id="article-150598.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Patients with mild to moderate symptoms usually respond well to nutritional therapy.<xref ref-type="bibr" rid="article-150598.r3">[3]</xref>&#x000a0;However, only limited data are available regarding the proportion of people with post-bariatric surgery hypoglycemia requiring pharmacotherapy, with pharmacotherapy failure requiring surgery for correction and failure of surgery to correct this condition.&#x000a0;</p>
        <p>A recent retrospective observational study of patients with post-bariatric surgery hypoglycemia reported on outcomes of patients who had failed nutritional therapy. It defined the efficacy of medication as &#x0201c;greater than fifty percent reduction of hypoglycemic symptoms and as a combination of no or almost no hypoglycemic events.&#x0201d; In this study, overall reported medication efficacy ranged from 45 to 80%. Approximately 20% of the patients were referred for surgical treatment due to the failure of conservative measures. About 63% of the patients who underwent surgery reported complete resolution of the symptoms, about 16% reported 50 to 100% resolution of the symptoms, and no improvement was reported in 21%. Different types of surgeries had different efficacies.<xref ref-type="bibr" rid="article-150598.r30">[30]</xref>&#x000a0;However, more studies are needed to draw firm conclusions. Persistent symptoms can have profound effects on quality of life.</p>
      </sec>
      <sec id="article-150598.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Severe hypoglycemia can be associated with signs and symptoms such as anxiety, irritability, slurred speech, shakiness, disorientation, agitation, seizures, loss of consciousness, and even death.&#x000a0;</p>
        <p>Repeated episodes of hypoglycemia can result in a condition called &#x0201c;hypoglycemia unawareness,&#x0201d; wherein despite low blood sugar levels, the counter-regulatory responses are blunted, and the symptoms of hypoglycemia diminish over time. A study in patients with post-bariatric surgery hypoglycemia demonstrated impaired driving performance associated with low glucose levels even in the absence of symptoms of hypoglycemia.<xref ref-type="bibr" rid="article-150598.r30">[30]</xref></p>
        <p>In patients with diabetes mellitus, hypoglycemia can also have insidious harmful effects on various organ systems, significantly affecting the quality of life. However, the long-term effects of post-bariatric surgery hypoglycemia are unknown.<xref ref-type="bibr" rid="article-150598.r31">[31]</xref></p>
      </sec>
      <sec id="article-150598.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>The risk factors for developing post-bariatric surgery hypoglycemia are not entirely understood; hence, more data is needed to inform patient selection to avoid this condition. Individuals considering bariatric surgery for weight loss should be aware of the symptoms of post-bariatric surgery hypoglycemia, its effects on quality of life, and the treatment options.&#x000a0;</p>
        <p>Avoiding large meals with simple carbohydrates and consuming small, frequent meals rich in protein, healthy fats, and fiber may help improve symptoms. Pharmacotherapy can be considered for people who do not respond to dietary changes. Patients who fail conservative measures may need surgical interventions to treat this condition.</p>
      </sec>
      <sec id="article-150598.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Post-bariatric surgery hypoglycemia is usually a late complication of weight loss surgeries.&#x000a0;It has been thought of as post-prandial hypoglycemia; however, meal-independent hypoglycemia is also recognized.&#x000a0;It can present with symptoms of hypoglycemia; however, in some cases, hypoglycemia can be asymptomatic and still affect cognition.&#x000a0;Treatment options include nutritional therapy, pharmacotherapy, and surgery.</p>
      </sec>
      <sec id="article-150598.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Clinicians should be aware of this complication and discuss the possibility during pre-surgery counseling. Patients should meet with a clinical nutritionist before the procedure and determine whether the dietary changes required pre and post-procedure are feasible.</p>
        <p>If a patient develops this complication, an interprofessional team comprising primary care providers, surgeons, endocrinologists, nutritionists, and pharmacists may help develop strategies to manage this condition. More data is needed to establish specific standards for multidisciplinary evaluation. The primary treatment is dietary modification; pharmacotherapy may be added if symptoms persist. In patients who have failed conservative measures, surgical therapies may be considered. The recommendations for treating post-bariatric surgery hypoglycemia are based on case series and expert opinion. [Level 5]</p>
      </sec>
      <sec id="article-150598.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=150598&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=150598">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/gut-health/postbariatric-surgery-hypoglycemia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=150598">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/150598/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=150598">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-150598.s17">
        <title>References</title>
        <ref id="article-150598.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bl&#x000fc;her</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Obesity: global epidemiology and pathogenesis.</article-title>
            <source>Nat Rev Endocrinol</source>
            <year>2019</year>
            <month>May</month>
            <volume>15</volume>
            <issue>5</issue>
            <fpage>288</fpage>
            <page-range>288-298</page-range>
            <pub-id pub-id-type="pmid">30814686</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dietz</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Baur</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Puhl</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Taveras</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Uauy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kopelman</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Management of obesity: improvement of health-care training and systems for prevention and care.</article-title>
            <source>Lancet</source>
            <year>2015</year>
            <month>Jun</month>
            <day>20</day>
            <volume>385</volume>
            <issue>9986</issue>
            <fpage>2521</fpage>
            <page-range>2521-33</page-range>
            <pub-id pub-id-type="pmid">25703112</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eisenberg</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Azagury</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Ghiassi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Grover</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>ASMBS Position Statement on Postprandial Hyperinsulinemic Hypoglycemia after Bariatric Surgery.</article-title>
            <source>Surg Obes Relat Dis</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>371</fpage>
            <page-range>371-378</page-range>
            <pub-id pub-id-type="pmid">28110984</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lupoli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lembo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ciciola</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Schiavo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pilone</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Capaldo</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Continuous glucose monitoring in subjects undergoing bariatric surgery: Diurnal and nocturnal glycemic patterns.</article-title>
            <source>Nutr Metab Cardiovasc Dis</source>
            <year>2020</year>
            <month>Oct</month>
            <day>30</day>
            <volume>30</volume>
            <issue>11</issue>
            <fpage>1954</fpage>
            <page-range>1954-1960</page-range>
            <pub-id pub-id-type="pmid">32807631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Schweitzer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Magnuson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Steele</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Koerner</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>TT</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of and risk factors for hypoglycemic symptoms after gastric bypass and sleeve gastrectomy.</article-title>
            <source>Obesity (Silver Spring)</source>
            <year>2015</year>
            <month>May</month>
            <volume>23</volume>
            <issue>5</issue>
            <fpage>1079</fpage>
            <page-range>1079-84</page-range>
            <pub-id pub-id-type="pmid">25866150</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Schweitzer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Magnuson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>The incidence and risk factors associated with developing symptoms of hypoglycemia after bariatric surgery.</article-title>
            <source>Surg Obes Relat Dis</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>797</fpage>
            <page-range>797-802</page-range>
            <pub-id pub-id-type="pmid">29678347</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poelemeijer</surname>
                <given-names>YQM</given-names>
              </name>
              <name>
                <surname>Liem</surname>
                <given-names>RSL</given-names>
              </name>
              <name>
                <surname>V&#x000e5;ge</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mala</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sundbom</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ottosson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nienhuijs</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Perioperative Outcomes of Primary Bariatric Surgery in North-Western Europe: a Pooled Multinational Registry Analysis.</article-title>
            <source>Obes Surg</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>28</volume>
            <issue>12</issue>
            <fpage>3916</fpage>
            <page-range>3916-3922</page-range>
            <pub-id pub-id-type="pmid">30027332</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Capristo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Panunzi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>De Gaetano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Spuntarelli</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bellantone</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Giustacchini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Birkenfeld</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Amiel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bornstein</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Raffaelli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mingrone</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Incidence of Hypoglycemia After Gastric Bypass vs Sleeve Gastrectomy: A Randomized Trial.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2018</year>
            <month>Jun</month>
            <day>01</day>
            <volume>103</volume>
            <issue>6</issue>
            <fpage>2136</fpage>
            <page-range>2136-2146</page-range>
            <pub-id pub-id-type="pmid">29590421</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brix</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kopp</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>H&#x000f6;llerl</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Schernthaner</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Ludvik</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schernthaner</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Frequency of Hypoglycaemia after Different Bariatric Surgical Procedures.</article-title>
            <source>Obes Facts</source>
            <year>2019</year>
            <volume>12</volume>
            <issue>4</issue>
            <fpage>397</fpage>
            <page-range>397-406</page-range>
            <pub-id pub-id-type="pmid">31234171</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kefurt</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Langer</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Schindler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shakeri-Leidenm&#x000fc;hler</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ludvik</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Prager</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Hypoglycemia after Roux-En-Y gastric bypass: detection rates of continuous glucose monitoring (CGM) versus mixed meal test.</article-title>
            <source>Surg Obes Relat Dis</source>
            <year>2015</year>
            <season>May-Jun</season>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>564</fpage>
            <page-range>564-9</page-range>
            <pub-id pub-id-type="pmid">25737101</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salehi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vella</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McLaughlin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Patti</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2018</year>
            <month>Aug</month>
            <day>01</day>
            <volume>103</volume>
            <issue>8</issue>
            <fpage>2815</fpage>
            <page-range>2815-2826</page-range>
            <pub-id pub-id-type="pmid">30101281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cummings</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Foster-Schubert</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Overduin</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Ghrelin and energy balance: focus on current controversies.</article-title>
            <source>Curr Drug Targets</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>153</fpage>
            <page-range>153-69</page-range>
            <pub-id pub-id-type="pmid">15777186</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sethi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Thillai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nain</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Ahuja</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Aulakh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Khurana</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Role of Hunger Hormone "Ghrelin" in Long-Term Weight Loss Following Laparoscopic Sleeve Gastrectomy.</article-title>
            <source>Niger J Surg</source>
            <year>2018</year>
            <season>Jul-Dec</season>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>121</fpage>
            <page-range>121-124</page-range>
            <pub-id pub-id-type="pmid">30283224</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Honka</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Salehi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Postprandial hypoglycemia after gastric bypass surgery: from pathogenesis to diagnosis and treatment.</article-title>
            <source>Curr Opin Clin Nutr Metab Care</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>295</fpage>
            <page-range>295-302</page-range>
            <pub-id pub-id-type="pmid">31082828</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Service</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Service</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Andrews</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Collazo-Clavell</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Lloyd</surname>
                <given-names>RV</given-names>
              </name>
            </person-group>
            <article-title>Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.</article-title>
            <source>N Engl J Med</source>
            <year>2005</year>
            <month>Jul</month>
            <day>21</day>
            <volume>353</volume>
            <issue>3</issue>
            <fpage>249</fpage>
            <page-range>249-54</page-range>
            <pub-id pub-id-type="pmid">16034010</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meier</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Galasso</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>PC</given-names>
              </name>
            </person-group>
            <article-title>Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover.</article-title>
            <source>Diabetes Care</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>29</volume>
            <issue>7</issue>
            <fpage>1554</fpage>
            <page-range>1554-9</page-range>
            <pub-id pub-id-type="pmid">16801578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cryer</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>Symptoms of hypoglycemia, thresholds for their occurrence, and hypoglycemia unawareness.</article-title>
            <source>Endocrinol Metab Clin North Am</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>495</fpage>
            <page-range>495-500, v-vi</page-range>
            <pub-id pub-id-type="pmid">10500927</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Szadkowska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Czy&#x0017c;ewska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pietrzak</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mianowska</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jarosz-Chobot</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>My&#x0015b;liwiec</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Hypoglycaemia unawareness in patients with type 1 diabetes.</article-title>
            <source>Pediatr Endocrinol Diabetes Metab</source>
            <year>2018</year>
            <volume>2018</volume>
            <issue>3</issue>
            <fpage>126</fpage>
            <page-range>126-134</page-range>
            <pub-id pub-id-type="pmid">30786677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <collab>International Hypoglycaemia Study Group</collab>
            <article-title>Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes.</article-title>
            <source>Diabetes Care</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>155</fpage>
            <page-range>155-157</page-range>
            <pub-id pub-id-type="pmid">27872155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bantle</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Ikramuddin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kellogg</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Buchwald</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Hyperinsulinemic hypoglycemia developing late after gastric bypass.</article-title>
            <source>Obes Surg</source>
            <year>2007</year>
            <month>May</month>
            <volume>17</volume>
            <issue>5</issue>
            <fpage>592</fpage>
            <page-range>592-4</page-range>
            <pub-id pub-id-type="pmid">17658016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Halperin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Patti</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Skow</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bajwa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goldfine</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Continuous glucose monitoring for evaluation of glycemic excursions after gastric bypass.</article-title>
            <source>J Obes</source>
            <year>2011</year>
            <volume>2011</volume>
            <fpage>869536</fpage>
            <pub-id pub-id-type="pmid">21331295</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prieto-Saldarriaga</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Builes-Monta&#x000f1;o</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Arango-Toro</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Manotas-Echeverry</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-Cadavid</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>&#x000c1;lvarez-Payares</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Arrieta</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Insulinoma-related Endogenous Hypoglycaemia with a Negative Fasting Test: A Case Report and Literature Review.</article-title>
            <source>Eur J Case Rep Intern Med</source>
            <year>2022</year>
            <volume>9</volume>
            <issue>9</issue>
            <fpage>003484</fpage>
            <pub-id pub-id-type="pmid">36299851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okabayashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sumiyoshi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kozuki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ogawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hanazaki</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of insulinoma.</article-title>
            <source>World J Gastroenterol</source>
            <year>2013</year>
            <month>Feb</month>
            <day>14</day>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>829</fpage>
            <page-range>829-37</page-range>
            <pub-id pub-id-type="pmid">23430217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suhl</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Anderson-Haynes</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Mulla</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Patti</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Medical nutrition therapy for post-bariatric hypoglycemia: practical insights.</article-title>
            <source>Surg Obes Relat Dis</source>
            <year>2017</year>
            <month>May</month>
            <volume>13</volume>
            <issue>5</issue>
            <fpage>888</fpage>
            <page-range>888-896</page-range>
            <pub-id pub-id-type="pmid">28392017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scarpellini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Arts</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Karamanolis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Laurenius</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Siquini</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ukleja</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Van Beek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vanuytsel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bor</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ceppa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Di Lorenzo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Emous</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hammer</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hellstr&#x000f6;m</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Laville</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lundell</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Masclee</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ritz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tack</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>International consensus on the diagnosis and management of dumping syndrome.</article-title>
            <source>Nat Rev Endocrinol</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>16</volume>
            <issue>8</issue>
            <fpage>448</fpage>
            <page-range>448-466</page-range>
            <pub-id pub-id-type="pmid">32457534</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ames</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lago-Hernandez</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Grunvald</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Hypoglycemia After Gastric Bypass Successfully Treated With Calcium Channel Blockers: Two Case Reports.</article-title>
            <source>J Endocr Soc</source>
            <year>2019</year>
            <month>Jul</month>
            <day>01</day>
            <volume>3</volume>
            <issue>7</issue>
            <fpage>1417</fpage>
            <page-range>1417-1422</page-range>
            <pub-id pub-id-type="pmid">31286108</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Craig</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Lawler</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CJE</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Glodowski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rogowitz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Karaman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>McLaughlin</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>PREVENT: A Randomized, Placebo-controlled Crossover Trial of Avexitide for Treatment of Postbariatric Hypoglycemia.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2021</year>
            <month>Jul</month>
            <day>13</day>
            <volume>106</volume>
            <issue>8</issue>
            <fpage>e3235</fpage>
            <page-range>e3235-e3248</page-range>
            <pub-id pub-id-type="pmid">33616643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferreira</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Emara</surname>
                <given-names>AFA</given-names>
              </name>
              <name>
                <surname>Herzig</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Melmer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vogt</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Nakas</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Facchinetti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dalla Man</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bally</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Study protocol for a randomised, double-blind, placebo-controlled crossover trial assessing the impact of the SGLT2 inhibitor empagliflozin on postprandial hypoglycaemia after gastric bypass.</article-title>
            <source>BMJ Open</source>
            <year>2022</year>
            <month>Sep</month>
            <day>19</day>
            <volume>12</volume>
            <issue>9</issue>
            <fpage>e060668</fpage>
            <pub-id pub-id-type="pmid">36123073</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ono</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hyogo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ochi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Munekage</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nozaki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hirose</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Masuda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mizuta</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Okamoto</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Saibara</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of postprandial hypoglycemia in patients with nonalcoholic fatty liver disease by oral glucose tolerance testing and continuous glucose monitoring.</article-title>
            <source>Eur J Gastroenterol Hepatol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>30</volume>
            <issue>7</issue>
            <fpage>797</fpage>
            <page-range>797-805</page-range>
            <pub-id pub-id-type="pmid">29634665</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Heide</surname>
                <given-names>LJM</given-names>
              </name>
              <name>
                <surname>Wouda</surname>
                <given-names>SHT</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>VJT</given-names>
              </name>
              <name>
                <surname>Oosterwerff-Suiker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gerdes</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Emous</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van Beek</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Medical and surgical treatment of postbariatric hypoglycaemia: Retrospective data from daily practice.</article-title>
            <source>Diabetes Obes Metab</source>
            <year>2023</year>
            <month>Mar</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>735</fpage>
            <page-range>735-747</page-range>
            <pub-id pub-id-type="pmid">36377811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-150598.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mukherjee</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Venkataraman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bantwal</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Shaikh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Saboo</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Ramachandran</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Hypoglycemia: The neglected complication.</article-title>
            <source>Indian J Endocrinol Metab</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>5</issue>
            <fpage>819</fpage>
            <page-range>819-34</page-range>
            <pub-id pub-id-type="pmid">24083163</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
